The heterocyclic aromatic amine 2-amino-3-methylimidazo[4,5-f]
quinoline (IQ) is a potent hepatocarcinogen in cynomolgus and rhesus monkeys. The finding of high cardiac
IQ-DNA adduct levels prompted a histopathological study of perfusion-fixed hearts from 10
tumor-bearing monkeys chronically dosed with IQ
at 10 mg/kg or 20 mg/kg 5 days per week for 48-80 months. Two monkeys dosed only with the vehicle for IQ,
hydroxypropylcellulose, served as controls. All the monkeys had normal heart weights, and no abnormalities were observed upon gross inspection of the hearts. Microscopically, focal myocardial lesions were observed in 8 of 10 monkeys dosed with IQ. Light microscopic abnormalities included myocyte
necrosis with or without chronic inflammatory infiltrates, interstitial
fibrosis with myocyte
hypertrophy or
atrophy, and
vasculitis. Electron microscopic findings included disruption of the mitochondrial architecture (i.e., mitochondrial swelling and clearing of matrix densities), myofibrillar loss, disorganization of the normal alignment of sarcomeres, and occasional myocytes showing nuclear
hypertrophy or peripheral clumping of the nuclear
chromatin. There was some correlation between the cumulative dose of IQ and the extent of the myocardial abnormalities. These findings suggest that chronic exposure to IQ can lead to myocardial damage in monkeys. Although focal and not associated with clinical evidence of
heart failure, these abnormalities may represent the initial stages of IQ-induced toxic
cardiomyopathy.